1. Home
  2. INTS vs BHAT Comparison

INTS vs BHAT Comparison

Compare INTS & BHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTS
  • BHAT
  • Stock Information
  • Founded
  • INTS 2012
  • BHAT 2010
  • Country
  • INTS United States
  • BHAT China
  • Employees
  • INTS N/A
  • BHAT N/A
  • Industry
  • INTS Biotechnology: Pharmaceutical Preparations
  • BHAT Recreational Games/Products/Toys
  • Sector
  • INTS Health Care
  • BHAT Consumer Discretionary
  • Exchange
  • INTS Nasdaq
  • BHAT Nasdaq
  • Market Cap
  • INTS 8.7M
  • BHAT 10.3M
  • IPO Year
  • INTS 2023
  • BHAT 2019
  • Fundamental
  • Price
  • INTS $0.46
  • BHAT $1.83
  • Analyst Decision
  • INTS Strong Buy
  • BHAT
  • Analyst Count
  • INTS 3
  • BHAT 0
  • Target Price
  • INTS $8.50
  • BHAT N/A
  • AVG Volume (30 Days)
  • INTS 1.3M
  • BHAT 758.4K
  • Earning Date
  • INTS 05-13-2025
  • BHAT 04-30-2025
  • Dividend Yield
  • INTS N/A
  • BHAT N/A
  • EPS Growth
  • INTS N/A
  • BHAT N/A
  • EPS
  • INTS N/A
  • BHAT N/A
  • Revenue
  • INTS N/A
  • BHAT $18,724,190.00
  • Revenue This Year
  • INTS N/A
  • BHAT N/A
  • Revenue Next Year
  • INTS N/A
  • BHAT N/A
  • P/E Ratio
  • INTS N/A
  • BHAT N/A
  • Revenue Growth
  • INTS N/A
  • BHAT N/A
  • 52 Week Low
  • INTS $0.29
  • BHAT $1.62
  • 52 Week High
  • INTS $5.10
  • BHAT $145.00
  • Technical
  • Relative Strength Index (RSI)
  • INTS 38.44
  • BHAT 43.79
  • Support Level
  • INTS $0.29
  • BHAT $1.62
  • Resistance Level
  • INTS $0.63
  • BHAT $1.99
  • Average True Range (ATR)
  • INTS 0.09
  • BHAT 0.12
  • MACD
  • INTS 0.06
  • BHAT 0.02
  • Stochastic Oscillator
  • INTS 50.88
  • BHAT 34.93

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

About BHAT Blue Hat Interactive Entertainment Technology

Blue Hat Interactive Entertainment Technology is a producer, developer, and operator of augmented reality (AR) interactive entertainment games and toys in China, including interactive educational materials, mobile games, and toys with mobile game features. The company's products include AR Racer, AR Crazy Bug, AR 3D Magic Box, AR Dinosaur, Talking Tom and Friends Bouncing Bubble, and Immersive Education Classes. The company reports in the following segments: Interactive toys - animation series, Interactive toys - game series, and Mobile games, Information services, and Communication services, out of which the majority of the revenue is generated from the game series. The majority of its revenues are generated in China.

Share on Social Networks: